Efficacy and Safety of Prophylaxis with a Plasma-Derived Von Willebrand Factor/ Factor VIII Concentrate in Previously Treated Patients with Von Willebrand Disease

被引：0

作者：

Sidonio, Robert F., Jr. ^{[1
]}

Boban, Ana ^{[2
]}

Dubey, Leonid ^{[3
]}

Inati, Adlette ^{[4
]}

Kiss, Csongor ^{[5
]}

Lissitchkov, Toshko ^{[6
]}

Novik, Dzmitry ^{[7
]}

Peteva, Elina ^{[8
]}

Taher, Ali T. ^{[9
]}

Timofeeva, Margarita Arkadevna ^{[10
]}

Vilchevska, Kateryna V. ^{[11
]}

Vdovin, Vladimir ^{[12
]}

Werner, Sylvia ^{[13
]}

Knaub, Sigurd ^{[14
]}

Khayat, Claudia ^{[15
]}

机构：

[1] Emory Univ, Dept Pediat, Sch Med, Atlanta, GA USA

[2] Zagreb Univ, Univ Hosp Ctr Zagreb, Dept Internal Med, Sch Med, Zagreb, Croatia

[3] Communal Nonprofit Enterprise Western Ukrainian S, Lvov, Ukraine

[4] Nini Hosp, Tripoli, Lebanon

[5] Univ Debrecen, Thrombosis & Haemostasis Ctr, Clin Ctr, Nagyerdei Campus, Debrecen, Hungary

[6] Specialized Hosp Act Treatment Hematol Dis, Clin Hematol Clin, Dept Chemotherapy Hemotherapy & Hereditary Blood, Sofia, Bulgaria

[7] Govt Agcy, Republican Res Ctr Radiat Med & Human Ecol, Gomel, BELARUS

[8] Univ Hosp St Marina Varna, Pediat Clin Haematol & Oncol, Varna, Bulgaria

[9] Amer Univ, Dept Internal Med, Div Hematol Oncol, Beirut Med Ctr, Beirut, Lebanon

[10] Fed Med & Biol Agcy, Deral State Budgetary Sci Inst, Kirov Sci Res Inst Hematol & Blood Transfus, Kirov, Russia

[11] Natl Specialized Childrens Hosp Okhmatdyt, Kiev, Ukraine

[12] Morozovskaya Childrens City Clin Hosp, Moscow, Russia

[13] Octapharma USA, Paramus, NJ USA

[14] Octapharma AG, Lachen, Switzerland

[15] St Joseph Univ, Hotel Dieu France Hosp, Beirut, Lebanon

来源：

BLOOD | 2022年 / 140卷

关键词：

D O I：

10.1182/blood-2022-162358

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：8438 / 8439

页数：2

共 50 条

[1] Effect of Factor VIII and Von Willebrand Factor Activities on Number of Bleeding Events in Previously Treated Patients with Von Willebrand Disease on Regular Prophylaxis with a Plasma-Derived Von Willebrand Factor/Factor VIII Concentrate
Vilchevska, Kateryna V.
Vdovin, Vladimir
Timofeeva, Margarita
Khayat, Claudia Djambas
Inati, Adlette
Robert, Sidonio F., Jr.
[J]. BLOOD, 2023, 142
[2] A Systematic Review of Efficacy and Safety of Plasma-Derived von Willebrand Factor/Factor VIII Concentrate (Voncento) in von Willebrand Disease
Rugeri, Lucia
Thomas, Will
Schirner, Kathrin
Heyder, Lisa
Auerswald, Guenter
[J]. THROMBOSIS AND HAEMOSTASIS, 2024, 124 (09) : 828 - 841
[3] Efficacy of Regular Prophylaxis with a Plasma-Derived Von Willebrand Factor/Factor VIII Concentrate in Reducing Nose Bleeds in Children and Adults with Von Willebrand Disease
Boban, Ana
Robert, Sidonio F., Jr.
Dubey, Leonid
Vilchevska, Kateryna V.
Inati, Adlette
Khayat, Claudia Djambas
[J]. BLOOD, 2023, 142
[4] Efficacy of Regular Prophylaxis with a Plasma-Derived Von Willebrand Factor/Factor VIII Concentrate in Reducing Heavy Menstrual Bleeding in Females with Von Willebrand Disease
Kiss, Csongor
Boda, Zoltan
Khayat, Claudia Djambas
Dubey, Leonid
Robert, Sidonio F., Jr.
[J]. BLOOD, 2023, 142
[5] A Plasma-Derived Von Willebrand Factor/Factor VIII Concentrate (Wilate)
不详
[J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2010, 52 (1340): : 46 - 47
[6] Immunogenicity of a Plasma-Derived Von Willebrand Factor/Factor VIII Concentrate during the Wil-31 Prophylaxis Study in Patients with Von Willebrand Disease
Khayat, Claudia Djambas
Robert, Sidonio F., Jr.
Pavlova, Anna
[J]. BLOOD, 2023, 142
[7] Hemostatic management of von Willebrand disease during childbirth with a plasma-derived von Willebrand factor/ factor VIII concentrate
Iorio, Alfonso
James, Paula
Ma, Alice
Srivastava, Alok
[J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2024, 22 (10) : 2739 - 2744
[8] Regular prophylaxis with a plasma-derived von Willebrand factor/factor VIII concentrate is effective for reducing nosebleeds in children and adults with von Willebrand disease
Boban, A.
Sidonio, R. F., Jr.
Dubey, L.
Vilchevska, K.
Inati, A.
Khayat, C. D.
[J]. HAEMOPHILIA, 2024, 30 : 20 - 20
[9] The safety of plasma-derived von Willebrand/factor VIII concentrates in the management of inherited von Willebrand disease
Federici, Augusto B.
[J]. EXPERT OPINION ON DRUG SAFETY, 2009, 8 (02) : 203 - 210
[10] Accumulation of factor VIII and von Willebrand factor during prophylaxis with a plasma-derived von Willebrand FACTOR/FACTOR VIII concentrate during the WIL-31 study
Kateryna, V. V.
Vdovin, V.
Timofeeva, M. A.
Khayat, C. D.
Inati, A.
Sidonio, R. F., Jr.
[J]. HAEMOPHILIA, 2024, 30 : 139 - 140

← 1 2 3 4 5 →